CompoAtlas

Euro K 8

Natural health product licensed in Canada

Licence holder
Euro-Pharm International Canada Inc.
NPN or DIN-HM
02242291
Status
Inactive licence
Licence date
4 December 2007
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
DIN de transition

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Potassium

Source : Chlorure de potassium

Potency : 8 mmol

600 mgNot calculated

Non-medicinal ingredients

Eau, Silicon dioxide colloïdal, Stéarate de magnésium, FD & C Jaune no. 6, Dioxyde de titane, Hydroxy methyl cellulose, Gélatine, Acide stéarique, Méthylcellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 5 Capsule ; maximum: 12 Capsuleminimum: 2 Tous les jours ; maximum: 4 Tous les jours
AdultesNot specifiedminimum: 3 Capsule ; maximum: 5 Capsuleminimum: 2 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Treatment or prevention of hypokalemia which does not result from dietart deficiency. Treatment of digitalis toxicity. Potassium replacement therapy. Electrolyte replenisher. For the treatment of metabolic alkalosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 02242291

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line